Organization | Hue University

Hue University Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial

2015

NCT02614404

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Hue University of Medicine and Pharmacy | Hue University of Medicine and Pharmacy, Hue University

Active Ingredients

Drugs in Phase 4 Trials (2)

ezetimibe (zetia) (1 trial)

simvastatin (zocor) (1 trial)

Drugs in Phase 2 Trials (3)

dihydroqinghaosu (1 trial)

imatinib (gleevec) (1 trial)

piperaquinoline (1 trial)

Drugs in Other Trials (4)

levocarnitine (carnitor) (1 trial)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

triptorelin (Trelstar) (1 trial)

vitamin e (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Hypercholesterolemia (Phase 4)

Kidney Diseases (Phase 4)

Malaria (Phase 2)

Malaria, Falciparum (Phase 2)

Renal Insufficiency, Chronic (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 9